Seroprevalence of anti-SARS-CoV-2 antibodies in Colombia, 2020: A population-based study

• Ngā kaituhi matua: Marcela Mercado-Reyes (Author), Jeadran Malagón-Rojas (Author), Isabel Rodríguez-Barraquer (Author), Silvana Zapata-Bedoya (Author), Magdalena Wiesner (Author), Zulma Cucunubá (Author), Yesith Guillermo Toloza-Pérez (Author), Juan P. Hernández-Ortiz (Author), Jorge Acosta-Reyes (Author), Eliana Parra-Barrera (Author), Edgar Ibáñez-Beltrán (Author), Gianni G Quinche (Author), Lyda Muñoz-Galindo (Author), Vivian Rubio (Author), Marisol Galindo-Borda (Author), Erickson G Osorio-Velázquez (Author), Andrea Bermúdez-Forero (Author), Nelson Pinto-Chacón (Author), Gloria Puerto-Castro (Author), Carlos Franco-Muñoz (Author), María Isabel Estupiñan (Author), Luis Ángel Villar (Author), Nancy Gore-Saravia (Author), María Consuelo Miranda-Montoya (Author), Jaime Castellanos (Author), Edna Margarita Valle (Author), Edgar Navarro-Lechuga (Author), Juan Daniel Oviedo (Author), Martha Ospina-Martínez (Author)
• Hōputu: Pukapuka
• I whakaputaina: Elsevier, 2022-05-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Summary: Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to cause very high morbidity and mortality throughout Latin American countries. However, few population-based seroprevalence surveys have been conducted to quantify attack rates and characterize drivers of tr...